Answer
Yes. Kidney impairment reduces clearance and can increase exposure and bleeding risk, so it affects prescribing and monitoring.
Sources for this answer
- Aggrastat 50 mcg/ml Solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.